14-day Premium Trial Subscription Try For FreeTry Free
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclos
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled in
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric balloon
The Global Intragastric Balloons Market will grow by USD 144.87 mn during 2020-2024
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled in
Obesity treatment company said it only has enough cash and equivalents on hand to fund its operations through the end of the year
SAN DIEGO, June 19, 2020 -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric.
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80%
Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-fill
Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon system for t
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SLANG Worldwide (SLGWF), Stryker (SYK) and BioMarin
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on SLANG Worldwide
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM), with a price target of $370.00. The company's
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE